Hospira a Pfizer Company recalls Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15 mL, Single-dose, Caution: Mus
Recalled August 9, 2017 · FDA recall D-1046-2017 · Hospira a Pfizer
Hazard
Lack of Sterility Assurance · FDA Class II
Units
20,337,650 15 mL single dose vials
Sold at
U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore
Description
Lack of Sterility Assurance
Product
Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15 mL, Single-dose, Caution: Must Be Diluted, Rx Only, Mfd by Hospira, Inc. Lake Forest, IL 60045 USA, NDC: 0409-7295-01
Manufacturer(s)
Hospira a Pfizer Company
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →